Pharmacy Medical Policy Updates - Correction
It has been brought to our attention that some of the links were incorrect in the Pharmacy Medical Policy Updates sent on 5/2/22. Below are the corrected links.
Effective June 1, 2022:
- Site of Care Infusion Management
- IL-5 Inhibitors
- Opioids ER
- ATTR Amyloidosis
- ATTR Amyloidosis – Onpattro
- DPP-4 Inhibitors
- Rapid to Intermediate Acting Insulin
We apologize for any inconvenience this may has caused. If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.